ACSS2-mediated NF-κB activation promotes alkaliptosis in human pancreatic cancer cells

Abstract Alkaliptosis is a recently discovered type of pH-dependent cell death used for tumor therapy. However, its underlying molecular mechanisms and regulatory networks are largely unknown. Here, we report that the acetate-activating enzyme acetyl-CoA short-chain synthase family member 2 (ACSS2)...

Full description

Bibliographic Details
Main Authors: Dongwen Que, Feimei Kuang, Rui Kang, Daolin Tang, Jiao Liu
Format: Article
Language:English
Published: Nature Portfolio 2023-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-28261-4
_version_ 1811175794136842240
author Dongwen Que
Feimei Kuang
Rui Kang
Daolin Tang
Jiao Liu
author_facet Dongwen Que
Feimei Kuang
Rui Kang
Daolin Tang
Jiao Liu
author_sort Dongwen Que
collection DOAJ
description Abstract Alkaliptosis is a recently discovered type of pH-dependent cell death used for tumor therapy. However, its underlying molecular mechanisms and regulatory networks are largely unknown. Here, we report that the acetate-activating enzyme acetyl-CoA short-chain synthase family member 2 (ACSS2) is a positive regulator of alkaliptosis in human pancreatic ductal adenocarcinoma (PDAC) cells. Using qPCR and western blot analysis, we found that the mRNA and protein expression of ACSS2 was upregulated in human PDAC cell lines (PANC1 and MiaPaCa2) in response to the classic alkaliptosis activator JTC801. Consequently, the knockdown of ACSS2 by shRNAs inhibited JTC801-induced cell death in PDAC cells, and was accompanied by an increase in cell clone formation and a decrease in intracellular pH. Mechanically, ACSS2-mediated acetyl-coenzyme A production and subsequent histone acetylation contributed to NF-κB–dependent CA9 downregulation, and this effect was enhanced by the histone deacetylase inhibitor trichostatin A. These findings may provide new insights for understanding the metabolic basis of alkaliptosis and establish a potential strategy for PDAC treatment.
first_indexed 2024-04-10T19:42:47Z
format Article
id doaj.art-2411754a82c148c691fdabbb86a40bf2
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-10T19:42:47Z
publishDate 2023-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-2411754a82c148c691fdabbb86a40bf22023-01-29T12:12:54ZengNature PortfolioScientific Reports2045-23222023-01-0113111010.1038/s41598-023-28261-4ACSS2-mediated NF-κB activation promotes alkaliptosis in human pancreatic cancer cellsDongwen Que0Feimei Kuang1Rui Kang2Daolin Tang3Jiao Liu4The DAMP Laboratory, Third Affiliated Hospital of Guangzhou Medical UniversityThe DAMP Laboratory, Third Affiliated Hospital of Guangzhou Medical UniversityDepartment of Surgery, UT Southwestern Medical CenterDepartment of Surgery, UT Southwestern Medical CenterThe DAMP Laboratory, Third Affiliated Hospital of Guangzhou Medical UniversityAbstract Alkaliptosis is a recently discovered type of pH-dependent cell death used for tumor therapy. However, its underlying molecular mechanisms and regulatory networks are largely unknown. Here, we report that the acetate-activating enzyme acetyl-CoA short-chain synthase family member 2 (ACSS2) is a positive regulator of alkaliptosis in human pancreatic ductal adenocarcinoma (PDAC) cells. Using qPCR and western blot analysis, we found that the mRNA and protein expression of ACSS2 was upregulated in human PDAC cell lines (PANC1 and MiaPaCa2) in response to the classic alkaliptosis activator JTC801. Consequently, the knockdown of ACSS2 by shRNAs inhibited JTC801-induced cell death in PDAC cells, and was accompanied by an increase in cell clone formation and a decrease in intracellular pH. Mechanically, ACSS2-mediated acetyl-coenzyme A production and subsequent histone acetylation contributed to NF-κB–dependent CA9 downregulation, and this effect was enhanced by the histone deacetylase inhibitor trichostatin A. These findings may provide new insights for understanding the metabolic basis of alkaliptosis and establish a potential strategy for PDAC treatment.https://doi.org/10.1038/s41598-023-28261-4
spellingShingle Dongwen Que
Feimei Kuang
Rui Kang
Daolin Tang
Jiao Liu
ACSS2-mediated NF-κB activation promotes alkaliptosis in human pancreatic cancer cells
Scientific Reports
title ACSS2-mediated NF-κB activation promotes alkaliptosis in human pancreatic cancer cells
title_full ACSS2-mediated NF-κB activation promotes alkaliptosis in human pancreatic cancer cells
title_fullStr ACSS2-mediated NF-κB activation promotes alkaliptosis in human pancreatic cancer cells
title_full_unstemmed ACSS2-mediated NF-κB activation promotes alkaliptosis in human pancreatic cancer cells
title_short ACSS2-mediated NF-κB activation promotes alkaliptosis in human pancreatic cancer cells
title_sort acss2 mediated nf κb activation promotes alkaliptosis in human pancreatic cancer cells
url https://doi.org/10.1038/s41598-023-28261-4
work_keys_str_mv AT dongwenque acss2mediatednfkbactivationpromotesalkaliptosisinhumanpancreaticcancercells
AT feimeikuang acss2mediatednfkbactivationpromotesalkaliptosisinhumanpancreaticcancercells
AT ruikang acss2mediatednfkbactivationpromotesalkaliptosisinhumanpancreaticcancercells
AT daolintang acss2mediatednfkbactivationpromotesalkaliptosisinhumanpancreaticcancercells
AT jiaoliu acss2mediatednfkbactivationpromotesalkaliptosisinhumanpancreaticcancercells